<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl1">
 <label>Table</label>
 <caption>
  <p>Distinct Features of Kawasaki Disease and Coronavirus Infections</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Kawasaki Disease</th>
    <th>Coronavirus Infections</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>No virus can be isolated from cultures of clinical specimens (
     <xref rid="bib21" ref-type="bibr">21</xref>, 
     <xref rid="bib22" ref-type="bibr">22</xref>)
    </td>
    <td>Virus can be isolated from cultures of clinical specimens</td>
   </tr>
   <tr>
    <td>No coronavirus is identified by high throughput RNA sequencing of tissues from KD patients (
     <xref rid="bib18" ref-type="bibr">18</xref>, 
     <xref rid="bib23" ref-type="bibr">23</xref>, 
     <xref rid="bib24" ref-type="bibr">24</xref>)
    </td>
    <td>Virus can be identified by high throughput RNA sequencing of tissues from infected patients</td>
   </tr>
   <tr>
    <td>No signal exists for serologic cross reactivity with coronaviruses, even using new highly sensitive VirScan method (
     <xref rid="bib21" ref-type="bibr">21</xref>, 
     <xref rid="bib22" ref-type="bibr">22</xref>, 
     <xref rid="bib23" ref-type="bibr">23</xref>)
    </td>
    <td>Serologic cross reactivity occurs with other coronaviruses, particularly those in the same subfamily (
     <xref rid="bib25" ref-type="bibr">25</xref>)
    </td>
   </tr>
   <tr>
    <td>Recurrence is rare; disease is rare in adolescents and adults</td>
    <td>Immunity wanes and infections with most coronaviruses generally recur lifelong (
     <xref rid="bib26" ref-type="bibr">26</xref>)
    </td>
   </tr>
   <tr>
    <td>Numerous RT-PCR studies investigating coronavirus as potential cause have been negative</td>
    <td>Viral RNA is consistently detected in patient samples by RT-PCR</td>
   </tr>
   <tr>
    <td>Inclusion bodies have been identified in ciliated bronchial epithelium that are targeted by antibodies from KD patients (
     <xref rid="bib18" ref-type="bibr">18</xref>); virus-like particles found adjacent to inclusion bodies are about 50 nm in diameter (
     <xref rid="bib17" ref-type="bibr">17</xref>)
    </td>
    <td>No inclusion bodies are identifiable in bronchial epithelium; virus particles are âˆ¼120 nm in diameter</td>
   </tr>
   <tr>
    <td>Patients have an antigen-driven immune response that is not directed at coronavirus (
     <xref rid="bib18" ref-type="bibr">18</xref>)
    </td>
    <td>Immune response is directed at coronavirus</td>
   </tr>
   <tr>
    <td>Coronary artery aneurysms occur; thrombosis is limited to within aneurysms</td>
    <td>Hypercoagulability with vascular thrombosis at multiple sites is characteristic of SARS-CoV-2 infection; coronary artery aneurysms are not reported in acute SARS-CoV-2 infection; autopsy in the only pediatric patient reported to date with cardiac death from SARS-CoV-2 showed eosinophilic myocarditis with no evidence of vascular inflammation(27)</td>
   </tr>
   <tr>
    <td>Epidemiologic and histologic evidence supports the hypothesis of persistent infection (
     <xref rid="bib28" ref-type="bibr">28</xref>, 
     <xref rid="bib29" ref-type="bibr">29</xref>)
    </td>
    <td>There is no persistent infection</td>
   </tr>
   <tr>
    <td>Median age of patients with KD-associated shock is 2.8 yrs (
     <xref rid="bib30" ref-type="bibr">30</xref>)
    </td>
    <td>Median age of patients with SARS-CoV-2 associated pediatric shock is is 9-10 years (
     <xref rid="bib1" ref-type="bibr">1</xref>, 
     <xref rid="bib7" ref-type="bibr">7</xref>)
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
